Steven J Cohen
Overview
Explore the profile of Steven J Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
3643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Micaily I, Blais E, Carhart R, Lam S, Cohen S, Cannaday S, et al.
JCO Precis Oncol
. 2023 Dec;
7:e2200648.
PMID: 38085059
Purpose: Pancreatic adenocarcinoma is an aggressive disease with poor clinical outcomes. Primary pancreatic tumors originating from the head of the pancreas (H) have different prognostic implications than tumors arising from...
2.
Stockton S, Catalano P, Cohen S, Burtness B, Mitchell E, Dotan E, et al.
Oncologist
. 2023 Apr;
28(9):827-e822.
PMID: 37104870
Background: Patients with advanced esophageal cancer carry poor prognoses; limited data exist to guide second-line therapy in the metastatic setting. Paclitaxel has been used yet is associated with limited efficacy....
3.
Scott A, Basu Mallick A, Dotan E, Cohen S, Gold P, Hochster H, et al.
Cancer Res Commun
. 2023 Mar;
2(10):1188-1196.
PMID: 36969746
Purpose: Multi-tyrosine kinase inhibitors (TKI) have shown clinical activity in patients with metastatic colorectal cancer. Cabozantinib, a multi-TKI, exhibited potent antitumor activity superior to regorafenib in preclinical colorectal cancer patient-derived...
4.
Atodaria K, Cohen S, Dhruv S, Ginnaram S, Shah S
Cureus
. 2022 Oct;
14(9):e29351.
PMID: 36284807
Background and objective The prognosis of pancreatic cancer (PC) is generally poor. PC responds only modestly to chemotherapy and chemoradiation, and surgical resection remains the only curative option. The risk...
5.
Sinicrope F, Shi Q, Smyrk T, Goldberg R, Cohen S, Gill S, et al.
JNCI Cancer Spectr
. 2021 Sep;
5(5).
PMID: 34485815
Background: Adipocyte-derived adiponectin may play a role in the host inflammatory response to cancer. We examined the association of plasma adiponectin with the density of tumor-infiltrating lymphocytes (TILs) in colon...
6.
Zhang E, Wang L, Shaikh T, Handorf E, Wong J, Hoffman J, et al.
Ann Surg Oncol
. 2021 Jun;
29(1):354-363.
PMID: 34114181
Background: Many studies show significantly improved survival after R0 resection compared with R1 resection in pancreatic adenocarcinoma (PAC); however, the effect of neoadjuvant chemoradiation (NACRT) on this association is unknown....
7.
McGhee-Jez A, Chervoneva I, Yi M, Ahuja A, Nahar R, Shah S, et al.
J Pancreat Cancer
. 2021 Jun;
7(1):23-30.
PMID: 34095739
Current literature reports increased incidence of postpancreaticoduodenectomy (PD) nonalcoholic fatty liver disease (NAFLD), a precursor for nonalcoholic steatohepatitis and cirrhosis. The incidence of and risk factors (RFs) for NAFLD in...
8.
Deng A, Wang C, Cohen S, Winter J, Posey J, Yeo C, et al.
Eur J Cancer
. 2021 Feb;
147:17-28.
PMID: 33607382
Purpose: To compare overall survival (OS) in patients who underwent surgery for early-stage pancreatic adenocarcinoma (rPca) based on sequence (NAT, neoadjuvant therapy and/or AT, adjuvant therapy) and type (SA, single-agent...
9.
Winer A, Denlinger C, Vijayvergia N, Cohen S, Astaturov I, Dotan E, et al.
Clin Colorectal Cancer
. 2020 Sep;
20(1):e43-e52.
PMID: 32972830
Background: Quinacrine plus a fluoropyrimidine has in vivo efficacy against metastatic colorectal cancer (mCRC). This phase 1b trial evaluated the combination of quinacrine plus capecitabine in patients with treatment-refractory mCRC....
10.
Dotan E, Cardin D, Lenz H, Messersmith W, ONeil B, Cohen S, et al.
Clin Cancer Res
. 2020 Jul;
26(20):5348-5357.
PMID: 32694153
Purpose: The recombinant fusion protein ipafricept blocks Wnt signaling, and in combination with gemcitabine and nab-paclitaxel caused tumor regression in xenografts. This phase Ib study evaluated the combination of ipafricept...